Microcephaly is a neurological condition defined by a head circumference (OC) more than 2 standard deviations (SD) below the mean for age and sex, with severe cases defined as more than 3 SD below the mean. This condition reflects underlying abnormal brain development or postnatal brain growth arrest and is associated with a wide spectrum of etiologies, including genetic mutations, congenital infections, metabolic disorders, and environmental insults. Microcephaly may be present at birth (congenital microcephaly) or develop postnatally during the first years of life (postnatal microcephaly).
The condition serves as a clinical marker for abnormal brain development, with the degree of microcephaly often correlating with the severity of neurodevelopmental outcomes. Children with microcephaly typically present with varying degrees of intellectual disability, developmental delays, motor impairments, and often have accompanying seizures. The prognosis depends largely on the underlying etiology, with genetic forms often having stable or progressive deficits, while acquired forms may show some recovery depending on the timing and nature of the insult.
Microcephaly gained significant public attention during the 2015-2016 Zika virus outbreak in Brazil, when a dramatic increase in cases was linked to prenatal Zika infection, demonstrating the condition's importance as a sentinel public health event.
Primary microcephaly (also called congenital microcephaly) is present at birth and results from impaired brain development during pregnancy. The head is proportionally small, reflecting reduced brain volume from early in gestation.
Secondary microcephaly develops after birth, typically in the first two years of life, due to disrupted brain growth. The head may be normal-sized at birth but fails to grow appropriately, often with a deceleration in head growth rate.
Based on underlying genetic mechanisms:
- Megalencephalic leukoencephalopathy with subcortical cysts (MLC1): See MLC1
- ASPM-related microcephaly: Mutations in ASPM gene
- CENPJ-related microcephaly: See CENPJ
- WDR62-related microcephaly: See WDR62
- MCPH (Microcephaly Primary Hereditary) genes: A group of 25+ genes causing isolated autosomal recessive microcephaly
Microcephaly can be isolated or part of broader syndromes:
- Down syndrome (Trisomy 21)
- Cri du Chat syndrome (5p deletion)
- Miller-Dieker syndrome (17p13.3 deletion)
- Angelman syndrome
- Rubinstein-Taybi syndrome
Over 25 genes have been implicated in primary microcephaly, collectively termed MCPH genes. These include:
- ASPM (MCPH5): Most common cause of autosomal recessive microcephaly; encodes a protein involved in mitotic spindle orientation in neural progenitor cells
- CENPJ (MCPH6): Centromere protein involved in centriole replication
- WDR62 (MCPH2): WD repeat protein involved in cell division
- CEP152 (MCPH4): Centromere protein involved in DNA repair
- CEP135 (MCPH8): Centriolar protein
- STIL (MCPH7): SIL/TAL-1 interacting protein
These genes share a common function in the centrosome, which is critical for proper cell division during brain development. Mutations impair the symmetric division of neural progenitor cells, reducing the number of neurons produced during cortical neurogenesis.
Some forms of microcephaly show autosomal dominant inheritance, often with variable expressivity:
- CHD1L mutations
- KAT6B mutations (associated with Rubinstein-Taybi syndrome)
- LMNB1 duplications
- APEX1 mutations
- CASK mutations (associated with brain malformations and microcephaly)
- HCFC1 mutations
The MCPH genes function in neuronal progenitor cell biology:
- Spindle orientation: Proper orientation determines whether progenitor cells divide symmetrically (expanding the pool) or asymmetrically (producing neurons)
- Centrosome function: Critical for proper chromosome segregation
- DNA damage response: Genomic stability affects neural progenitor survival
- Cell cycle regulation: Abnormal cell cycle kinetics reduce proliferation
The fundamental pathophysiology involves disrupted cortical neurogenesis:
- Reduced neural progenitor proliferation: Fewer progenitor cells during development
- Accelerated neuronal differentiation: Progenitors differentiate prematurely
- Increased apoptosis: Enhanced cell death during development
- Impaired neuronal migration: Abnormal cortical layering
- Reduced cortical volume: Thin cortex with simplified gyral patterns
MRI characteristics vary by etiology:
- Simplified gyral pattern: Reduced cortical folding
- Lissencephaly: Smooth brain surface in severe cases
- Periventricular nodular heterotopia: Neuronal migration abnormalities
- Corpus callosum hypoplasia: Often thin or absent
- Cerebellar hypoplasia: Particularly in some genetic forms
- Ventricular enlargement: Often prominent in severe cases
Key signaling pathways implicated:
- Sonic hedgehog (SHH): Critical for cortical development
- Wnt/β-catenin: Neurogenesis and patterning
- mTOR signaling: Growth and proliferation
- DNA damage response: Genomic stability
| Gene/Category | Inheritance | Features |
|---------------|--------------|-----------|
| MCPH genes | AR | Isolated microcephaly, normal facial features |
| Chromosomal | Variable | Often with dysmorphism and other anomalies |
| Syndromic | AR/AD/XL | Multiple system involvement |
- Cytomegalovirus (CMV): Most common congenital viral infection
- Zika virus: Associated with severe microcephaly ("congenital Zika syndrome")
- Toxoplasma gondii: Characteristic intracranial calcifications
- Rubella: During early pregnancy
- Herpes simplex virus: Rare but severe
- Syphilis: Treponema pallidum
- Prenatal alcohol exposure: Fetal alcohol spectrum disorders
- Maternal malnutrition: Particularly folate deficiency
- Maternal diabetes: Hyperglycemia effects on brain development
- Hypoxia-ischemia: Perinatal brain injury
- Postnatal brain injury: Infections, trauma, strokes
- Inborn errors of metabolism: Various organic acidurias, mitochondrial disorders
- Endocrine disorders: Congenital hypothyroidism
- Severe malnutrition: Early childhood
- Prematurity: Intraventricular hemorrhage
- Meningoencephalitis: Post-infectious brain damage
- Hydrocephalus: Ex vacuo reduction in brain volume
- Small head circumference: <2-3 SD below mean
- Dysmorphic features: Vary by etiology
- Neurological signs: Hypertonia, hypotonia, seizures
- Growth failure: Often associated
- Visual impairment: Optic atrophy in some forms
- Global developmental delay: Variable severity
- Intellectual disability: Present in majority
- Motor delays: Sitting, walking delayed
- Speech/language delays: Often severe
- Behavioral features: Autism spectrum disorders common
- Epilepsy: 30-50% develop seizures
- Cerebral palsy: In severe cases
- Vision/hearing impairments: Common
- Feeding difficulties: Especially in infants
- Autism spectrum disorder: Increased risk
- CMV: Periventricular calcifications, growth restriction
- Zika: Severe microcephaly, brain calcifications, arthrogryposis
- Down syndrome: Characteristic facial features, cardiac anomalies
- MCPH: Normal facies, proportionate short stature
- Head circumference measurement: Carefully plotted on growth charts
- Serial measurements: Track growth trajectory
- Family history: Consanguinity, similarly affected relatives
- Prenatal history: Infections, exposures, ultrasound findings
MRI brain is the imaging modality of choice:
- Assesses brain structure
- Identifies malformations
- Excludes hydrocephalus
- Guides genetic testing
CT may be useful for detecting calcifications (CMV, TORCH)
Chromosomal microarray (CMA):
- First-tier test for microcephaly
- Detects copy number variants
Whole exome sequencing (WES):
- Increasingly first-line for unexplained cases
- Identifies mutations in MCPH and other genes
- May identify treatable metabolic conditions
Targeted gene panels:
- Available for known microcephaly genes
- Newborn screening: For metabolic disorders
- Targeted testing: Based on clinical suspicion
Conditions to consider:
- Secondary microcephaly: Due to brain injury
- Acrocephalosyndactyly: e.g., Apert syndrome
- Primordial dwarfism: Proportionate small size
- Pseudomicrocephaly: Normal brain volume with small head
Management requires a team approach:
- Neurologist: Seizure control, overall management
- Developmental pediatrician: Coordination of care
- Geneticist: Diagnosis, counseling
- Physical/occupational therapy: Motor development
- Speech therapy: Communication
- Ophthalmology: Vision assessment
- Audiology: Hearing assessment
- Orthopedics: Joint contractures
- Seizure management: Antiepileptic drugs as needed
- Spasticity management: Baclofen, botox, physical therapy
- Developmental therapies: Early intervention services
- Feeding support: Gastrostomy tube if needed
- Vision/hearing aids: As appropriate
- Genetic counseling: Recurrence risk counseling
- Support groups: Connect with other families
- Resources: Educational materials, services
- Psychological support: For caregivers
The prognosis varies significantly by etiology:
- Isolated microcephaly without other anomalies
- Stable head growth (crossing percentiles is concerning)
- Normal brain structure on MRI
- No seizures or controlled seizures
- Severe microcephaly (>4 SD below mean)
- Accompanying brain malformations
- Progressive neurological decline
- Refractory seizures
- Associated syndromes with multi-system involvement
- Dependent on underlying cause
- Many live into adulthood
- Severe forms may have reduced life expectancy
- Quality of life often significantly impacted
Mouse models of microcephaly have been developed to study the condition:
- Aspm knockout mice: Show reduced brain size
- Cdk5rap2 mutants: Impaired neurogenesis
- Cenpj null mice: Lethal in utero
These models help understand the cellular mechanisms of human microcephaly.
Current research focuses on:
- Gene discovery: Identifying new causative genes
- Mechanism studies: Understanding how MCPH genes function
- Therapeutic development: Potential for treatment
- Epidemiology: Understanding risk factors
- Long-term outcomes: Natural history studies
- Preconception care: Optimize maternal health
- Genetic counseling: For at-risk families
- Carrier screening: In populations with high carrier rates
- Prenatal screening: Ultrasound detection
- Infection prevention: Vaccination, mosquito control
- Avoidance of teratogens: Alcohol, certain medications
- Early intervention: Maximize developmental potential
- Family support: Resources and education
- Medical management: Treat associated conditions